Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)

Ze Tian, Chunhua Shi, Guojun Yang, Jason K. Allen, Qing Shi, Amin AL-Shami, Jill Wardell Olson, Melinda G. Smith, Qing Chang, Jasbir Kaur, Junping You, Timothy E. Lofton, Michelle A. Gonzalez, Qi Zhang, Dong Xing Zha, Sarah K. Tasian, Nitin Jain, Marina Y. Konopleva, Timothy Heffernan, Jeffrey J. Molldrem

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (Leukemia, (2023), 37, 10, (2006-2016), 10.1038/s41375-023-02010-y)'. Together they form a unique fingerprint.

Medicine & Life Sciences